{"id":"clonidine-drug-intravenously","safety":{"commonSideEffects":[{"rate":null,"effect":"Hypotension"},{"rate":null,"effect":"Bradycardia"},{"rate":null,"effect":"Sedation"},{"rate":null,"effect":"Dry mouth"},{"rate":null,"effect":"Rebound hypertension (upon discontinuation)"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Clonidine binds to alpha-2 adrenergic receptors in the central nervous system, decreasing the release of norepinephrine and reducing sympathetic outflow. This results in decreased peripheral vascular resistance and lower blood pressure. When administered intravenously, it provides rapid onset of action for acute hypertensive episodes and perioperative hemodynamic management.","oneSentence":"Clonidine is an alpha-2 adrenergic agonist that reduces sympathetic nervous system activity, lowering blood pressure and heart rate.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:40:22.718Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypertension (acute management via intravenous route)"},{"name":"Perioperative hemodynamic control"},{"name":"Sedation and analgesia in intensive care settings"}]},"trialDetails":[{"nctId":"NCT04828226","phase":"PHASE4","title":"Clonidine to Prevent Delirium After Electroconvulsive Therapy.","status":"RECRUITING","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2021-04-27","conditions":"Major Depressive Disorder, Catatonia, Bipolar Disorder","enrollment":130},{"nctId":"NCT06507410","phase":"NA","title":"Additive Effects of Clonidine Used in Propofol Sedation in Colonoscopy","status":"RECRUITING","sponsor":"Tanta University","startDate":"2024-07-20","conditions":"Clonidine, Propofol, Sedation","enrollment":62},{"nctId":"NCT05091242","phase":"PHASE2, PHASE3","title":"The PREVENT AGITATION Trial II - Children ≤1 Year","status":"RECRUITING","sponsor":"Rigshospitalet, Denmark","startDate":"2021-10-25","conditions":"Emergence Delirium","enrollment":336},{"nctId":"NCT04737473","phase":"NA","title":"The Comparative Efficacy and Safety of Two General Anesthesia Protocols Consisting of Fentanyl Plus Propofol Plus Rococuronium Plus Isoflurane Versus Ketamime Plus Magnesium Sulphate Plus Lidocaine Plus Clonidine Plus Propofol Plus Rococuronium Plus Isoflurane for Gynaecology Surgery in Cameroon","status":"UNKNOWN","sponsor":"University of Yaounde 1","startDate":"2020-01-06","conditions":"Opioids, Clinical Trial, Anesthesia","enrollment":36},{"nctId":"NCT04026074","phase":"PHASE4","title":"Concepts for Analgosedation During Placement of Regional Anaesthesia Before Operations.","status":"COMPLETED","sponsor":"Medical University of Graz","startDate":"2019-07-26","conditions":"Knee Arthropathy, Hip Arthritis, Fractures, Closed","enrollment":50},{"nctId":"NCT00349921","phase":"PHASE2","title":"Clonidine Versus Adenosine to Treat Neuropathic Pain","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2004-08","conditions":"Pain","enrollment":24},{"nctId":"NCT00579085","phase":"PHASE2","title":"Double Blind Placebo Controlled Study of Outpatient Intravenous Ketamine for the Treatment of CRPS","status":"COMPLETED","sponsor":"Drexel University College of Medicine","startDate":"2006-09","conditions":"Complex Regional Pain Syndrome","enrollment":40},{"nctId":"NCT00279253","phase":"PHASE4","title":"Effects of Intravenous Clonidine on Ocular Blood Flow and Intraocular Pressure","status":"COMPLETED","sponsor":"Medical University of Vienna","startDate":"2004-03","conditions":"Physiology","enrollment":12}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"clonidine (drug) intravenously","genericName":"clonidine (drug) intravenously","companyName":"Medical University of Vienna","companyId":"medical-university-of-vienna","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Clonidine is an alpha-2 adrenergic agonist that reduces sympathetic nervous system activity, lowering blood pressure and heart rate. Used for Hypertension (acute management via intravenous route), Perioperative hemodynamic control, Sedation and analgesia in intensive care settings.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}